Loading...

NewAmsterdam Pharma Company N.V.

NAMS•NASDAQ
Healthcare
Biotechnology
$23.42
$-0.18(-0.76%)

NewAmsterdam Pharma Company N.V. (NAMS) Stock Chart & Performance Analysis

Explore NewAmsterdam Pharma Company N.V.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-6.05%
5-Day Change
-14.42%
1-Month Change
-36.24%
3-Month Change
-40.28%
6-Month Change
-15.44%
Year-to-Date (YTD) Change
-42.60%
1-Year Change
-21.99%
3-Year Change
51.27%
5-Year Change
40.41%
All-Time (Max) Change
40.41%

Analyzing NewAmsterdam Pharma Company N.V. (NAMS) Trends Across Multiple Time Frames

NewAmsterdam Pharma Company N.V. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. NewAmsterdam Pharma Company N.V. stock shows -6.05% 1-day change, indicating low volatility, while its 5-day change of -14.42% suggests a broader trend. Over a 1-month period, a -36.24% drop could signal a pullback, whereas a 3-month decline of -40.28% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -15.44% and a YTD drop of -42.60% might concern investors, but a 1-year loss of -21.99% and a 3-year increase of 51.27% could indicate resilience. The 5-year surge of 40.41% highlights strong historical growth, while the all-time return of 40.41% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;